NCLT sends amalgamation order to Sun Pharmaceutical Industries
Shital Jibhe / 16 Aug 2017
The approval received from the NCLT will be filed in E-Form INC-29 by the company with the Registrar of Companies, Gujarat and thereafter, the amalgamation shall be effective from the appointed date, April 1, 2017.
In a filing to the BSE, Sun Pharmaceutical Industries has stated that it has received an order passed by the National Company Law Tribunal (NCLT) in the matter of Scheme of Arrangement among Sun Pharma Medisales, Ranbaxy Drugs, Gufic Pharma, Vidyut Investments and the company, and their respective members and creditors.
The approval received from the NCLT will be filed in E-Form INC-29 by the company with the Registrar of Companies, Gujarat and thereafter, the amalgamation shall be effective from the appointed date, April 1, 2017.
Sun Pharma was trading at Rs 468 per share, down by Rs 4.50 or 0.95% as at 0921 hours on Wednesday, on the BSE.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.